Wall Street Analysts Predict a 26.53% Upside in Celldex (CLDX): Here's What You Should Know

Celldex Therapeutics (CLDX) closed the last trading session at $51.37, gaining 45.9% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by Wall Street analysts are any guide. The mean price target of $65 indicates a 26.5% upside potential.The average comprises seven short-term price targets ranging from a low of $27 to a high of $80, with a standard deviation of $18.18. While the lowest estimate indicates a decline of 47.4% from the current price ...